The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis
Open accessAbstract
Non-classical secretory vesicles, collectively referred to as extracellular vesicles (EVs), have been implicated in different aspects of cancer cell survival and metastasis. Here, we describe how a specific class of EVs, called microvesicles (MVs), activates VEGF receptors and tumour angiogenesis through a unique 90 kDa form of VEGF (VEGF 90K). We show that VEGF 90K is generated by the crosslinking of VEGF 165, catalysed by the enzyme tissue transglutaminase, and associates with MVs through its interaction with the chaperone Hsp90. We further demonstrate that MV-associated VEGF 90K has a weakened affinity for Bevacizumab, causing Bevacizumab to be ineffective in blocking MV-dependent VEGF receptor activation. However, treatment with an Hsp90 inhibitor releases VEGF 90K from MVs, restoring the sensitivity of VEGF 90K to Bevacizumab. These findings reveal a novel mechanism by which cancer cell-derived MVs influence the tumour microenvironment and highlight the importance of recognizing their unique properties when considering drug treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Indeed, there appear to be multiple contributors to the limitations observed with Bevacizumab and other angiogenesis drugs 24,52,55,56 .”
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Shedding microvesicles: artefacts no more
Cocucci, E., Racchetti, G., & Meldolesi, J. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.11.003 · Cited by 1,742
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Transglutaminases: crosslinking enzymes with pleiotropic functions
Lorand, L., & Graham, R. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1014 · Cited by 1,438
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
DeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Self-citationHigh Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabrò, L., Spada, M., Perdicchio, M., Marino, M. L., Federici, C., Iessi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005219 · Cited by 960
Microvesicles: mediators of extracellular communication during cancer progression
Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., & D'Souza-Schorey, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.064386 · Cited by 950
In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior
Zomer, A., Maynard, C., Verweij, F. J., Kamermans, A., Schäfer, R., Beerling, E., Schiffelers, R. M., de Wit, E., Berenguer, J., Ellenbroek, S. I. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.042 · Cited by 869
In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract
Arnaoutova, I., & Kleinman, H. K. (2010) · Nature Protocols · doi:10.1038/nprot.2010.6 · Cited by 760 · cited 1×
“Similar results were obtained when using an in vitro assay for angiogenesis that monitored the ability of HUVECs to undergo tubulogenesis 36 .”
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Vasudev, N. S., & Reynolds, A. R. (2014) · Angiogenesis · doi:10.1007/s10456-014-9420-y · Cited by 738
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
Ebos, J. M. L., & Kerbel, R. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.21 · Cited by 685
Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C., & Rak, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804543106 · Cited by 668
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G. A., Pitulescu, M. E., Acker, T., & Acker-Palmer, A. (2010) · Nature · doi:10.1038/nature08995 · Cited by 534
Antonyak, M. A., Li, B., Boroughs, L. K., Johnson, J. L., Druso, J. E., Bryant, K. L., Holowka, D. A., & Cerione, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017667108 · Cited by 497
Self-citationLee, T. H., D’Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B., & Rak, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0250-3 · Cited by 494
Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 481
Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches
McClellan, A. J., Xia, Y., Deutschbauer, A. M., Davis, R. W., Gerstein, M., & Frydman, J. (2007) · Cell · doi:10.1016/j.cell.2007.07.036 · Cited by 474
Daniel, V. C., Marchionni, L., Hierman, J. S., Rhodes, J. T., Devereux, W. L., Rudin, C. M., Yung, R., Parmigiani, G., Dorsch, M., Peacock, C. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4210 · Cited by 467
Liu, H., Patel, M. R., Prescher, J. A., Patsialou, A., Qian, D., Lin, J., Wen, S., Chang, Y.-F., Bachmann, M. H., Shimono, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006732107 · Cited by 465
Exosomes: Looking back three decades and into the future
Harding, C. V., Heuser, J. E., & Stahl, P. D. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212113 · Cited by 462
Induction of heat shock proteins in B-cell exosomes
Clayton, A., Turkes, A., Navabi, H., Mason, M. D., & Tabi, Z. (2005) · Journal of Cell Science · doi:10.1242/jcs.02494 · Cited by 454
Microvesicles: Messengers and mediators of tumor progression
Al-Nedawi, K., Meehan, B., & Rak, J. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8988 · Cited by 402
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 380
RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells
Li, B., Antonyak, M. A., Zhang, J., & Cerione, R. A. (2012) · Oncogene · doi:10.1038/onc.2011.636 · Cited by 377
Self-citationTargeting angiogenesis: progress with anti-VEGF treatment with large molecules
Grothey, A., & Galanis, E. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.110 · Cited by 356
Rak, J. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1267043 · Cited by 301
Tsutsumi, S., & Neckers, L. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00561.x · Cited by 239
Desrochers, L. M., Bordeleau, F., Reinhart-King, C. A., Cerione, R. A., & Antonyak, M. A. (2016) · Nature Communications · doi:10.1038/ncomms11958 · Cited by 229
Self-citationVEGF Receptor 2 Endocytic Trafficking Regulates Arterial Morphogenesis
Lanahan, A. A., Hermans, K., Claes, F., Kerley-Hamilton, J. S., Zhuang, Z. W., Giordano, F. J., Carmeliet, P., & Simons, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.016 · Cited by 228
Bioavailability of VEGF in Tumor-Shed Vesicles Depends on Vesicle Burst Induced by Acidic pH
Taraboletti, G., D'Ascenzoy, S., Giusti, I., Marchetti, D., Borsotti, P., Millimaggi, D., Giavazzi, R., Pavan, A., & Dolo, V. (2006) · Neoplasia · doi:10.1593/neo.05583 · Cited by 199
Jackson, M. W., Bentel, J. M., & Tilley, W. D. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64774-8 · Cited by 188
Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology
Desrochers, L. M., Antonyak, M. A., & Cerione, R. A. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.04.019 · Cited by 178
Self-citationLiu, X.-H., Kirschenbaum, A., Yao, S., Stearns, M. E., Holland, J. F., Claffey, K., & Levine, A. C. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006728119549 · Cited by 162
Hsp90: a chaperone for protein folding and gene regulation
Zhao, R., & Houry, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-158 · Cited by 144
Masson‐Gadais, B., Houle, F., Laferrière, J., & Huot, J. (2003) · Cell Stress and Chaperones · Cited by 123
Sanderson, S., Valenti, M. R., Gowan, S. M., Patterson, L., Ahmad, Z., Workman, P., & Eccles, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0439 · Cited by 118
Drug Insight: VEGF as a therapeutic target for breast cancer
Schneider, B. P., & Sledge, G. W. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0740 · Cited by 114
Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials
Mackey, J. R., Kerbel, R. S., Gelmon, K. A., McLeod, D., Chia, S., Rayson, D., Verma, S., Collins, L. L., Paterson, A. H. G., Robidoux, A., et al. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.12.002 · Cited by 107
Guérin, É., Man, S., Xu, P., & Kerbel, R. S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4183 · Cited by 86
Gourlaouen, M., Welti, J. C., Vasudev, N. S., & Reynolds, A. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446401 · Cited by 75
Press, J. Z., Kenyon, J. A., Xue, H., Miller, M. A., Luca, A. D., Miller, D. M., Huntsman, D. D., Gilks, C. B., McAlpine, J. N., & Wang, Y. Z. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.03.011 · Cited by 70
A self-renewal assay for cancer stem cells
Clarke, M. F. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0097-1 · Cited by 60
Tanespimycin as Antitumor Therapy
Dimopoulos, M. A., Mitsiades, C. S., Anderson, K. C., & Richardson, P. G. G. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.3816/clml.2011.n.002 · Cited by 42
Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer
Claudio Napoli, A., Giordano, A., Casamassimi, A., Pentimalli, F., Ignarro, L. J., & de Nigris, F. (2010) · International Journal of Cancer · doi:10.1002/ijc.25743 · Cited by 26
The role of antiangiogenesis therapy: Bevacizumab and beyond
Cortés-Funes, H. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0368-0 · Cited by 21
Cited by
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Glioblastoma stem‐like cells secrete the pro‐angiogenic VEGF‐A factor in extracellular vesicles
Treps, L., Perret, R., Edmond, S., Ricard, D., & Gavard, J. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1359479 · Cited by 277
Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease
Wang, S., Kojima, K., Mobley, J. A., & West, A. B. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.021 · Cited by 145
Forms of extracellular mitochondria and their impact in health
Miliotis, S., Nicolalde, B., Ortega, M., Yepez, J., & Caicedo, A. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.02.002 · Cited by 138
Matrix stiffness regulates microvesicle-induced fibroblast activation
Schwager, S. C., Bordeleau, F., Zhang, J., Antonyak, M. A., Cerione, R. A., & Reinhart-King, C. A. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00418.2018 · Cited by 50
Self-citation
Metadata
- Authors
- Feng, Q., Zhang, C., Lum, D., Druso, J. E., Blank, B., Wilson, K. F., Welm, A., Antonyak, M. A., & Cerione, R. A.
- Venue
- Nature Communications
- Published
- 2017-02-16
- Volume
- 8
- Issue
- 1
- Pages
- 14450-14450
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2588995471
- Cited by
- 256
- References
- 56
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.